Strength in numbers: Cooperative group clinical trials move the needle against pediatric cancer
Running a clinical trial requires enough patient participants to gather robust data so that researchers can draw appropriate conclusions...
Sep 16, 2024
FDA Grants Orphan Drug Designation to Opaganib in Neuroblastoma
The FDA has granted a second orphan drug designation to opaganib in oncology, this time for patients with neuroblastoma. Read more:...
Sep 13, 2024
First successful treatment of pediatric high-risk refractory neuroblastoma with PARP inhibition
Scientists and clinicians at St. Jude Children’s Research Hospital identified the genetic vulnerability BARD1 in a patient with pediatric...
Aug 30, 2024
Researchers identify malignant cells responsible for relapse in high-risk neuroblastoma
The study marks the first time that researchers identified malignant cells responsible for relapse in neuroblastoma and offers insights...
Aug 29, 2024
Discovery of Key Genetic Driver in Neuroblastoma Paves Way to New Therapeutic Approaches
Led by the Children’s Cancer Institute , a multi-institutional study published in Nature Communications has shown for the first time...
Aug 19, 2024
Florida hospital using Zika virus to help treat one of deadliest childhood cancers
Mosquitos — not only are they annoying — they can be deadly! The Zika virus is typically spread through mosquito bites. Now, a team of...
Jun 11, 2024
Research with mice suggests new treatment for children with neuroblastoma cancer
Researchers are looking for new treatments to increase children’s survival rates from neuroblastoma, a rare solid tumour of young...
May 29, 2024
Scientists discover new insight into the genetic pathway of neuroblastoma
Researchers from the University of Sheffield have created a stem cell model designed to investigate the origins of neuroblastoma, a...
May 28, 2024
Drug targeting RNA modifications shows promise for treating neuroblastoma
New research from the University of Chicago shows the potential for a promising new approach to treating neuroblastoma by targeting RNA...
May 24, 2024
A new era for treating high-risk neuroblastoma – research advances to look out for in 2024
It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed...
May 16, 2024

